Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Healthstream (HSTM) EBITDA Margin (2016 - 2025)

Healthstream (HSTM) has disclosed EBITDA Margin for 16 consecutive years, with 3.02% as the latest value for Q4 2025.

  • On a quarterly basis, EBITDA Margin fell 330.0% to 3.02% in Q4 2025 year-over-year; TTM through Dec 2025 was 6.66%, a 64.0% decrease, with the full-year FY2025 number at 7.94%, down 66.0% from a year prior.
  • EBITDA Margin was 3.02% for Q4 2025 at Healthstream, down from 9.89% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 9.89% in Q3 2025 to a low of 10.7% in Q4 2021.
  • A 5-year average of 4.34% and a median of 5.87% in 2023 define the central range for EBITDA Margin.
  • Peak YoY movement for EBITDA Margin: tumbled -1254bps in 2021, then skyrocketed 1493bps in 2023.
  • Healthstream's EBITDA Margin stood at 10.7% in 2021, then rose by 17bps to 8.89% in 2022, then skyrocketed by 168bps to 6.03% in 2023, then increased by 5bps to 6.32% in 2024, then tumbled by -52bps to 3.02% in 2025.
  • Per Business Quant, the three most recent readings for HSTM's EBITDA Margin are 3.02% (Q4 2025), 9.89% (Q3 2025), and 7.91% (Q2 2025).